Olympus Co. (OTCMKTS:OLYMY – Get Free Report) was the target of a large growth in short interest in the month of August. As of August 31st, there was short interest totaling 6,721 shares, a growth of 768.3% from the August 15th total of 774 shares. Based on an average trading volume of 49,485 shares, the short-interest ratio is presently 0.1 days.
Analysts Set New Price Targets
Separately, The Goldman Sachs Group cut Olympus from a “buy” rating to a “neutral” rating in a research report on Monday, June 15th. One investment analyst has rated the stock with a Hold rating, According to MarketBeat, the company currently has an average rating of “Hold”.
Read Our Latest Research Report on OLYMY
Olympus Stock Performance
About Olympus
Olympus Corporation is a Tokyo-based manufacturer specializing in precision technology for the medical, scientific and industrial markets. Established in 1919, the company has built an international reputation for optical and digital imaging solutions that encompass endoscopic systems, microscopes, cameras and related accessories. Olympus leverages its expertise in optics, mechanics and electronics to develop instruments designed to advance diagnostics and scientific discovery.
In the healthcare sector, Olympus is best known for its endoscopy products and therapeutic solutions that support minimally invasive procedures in gastroenterology, pulmonology and urology.
See Also
- Five stocks we like better than Olympus
- Rocket Lab Tackles a Supply Chain Bottleneck as the Stock Hunts for a Bottom. Time to Buy?
- Optical Cable Corporation Is Starting to Get the Market’s Attention
- Oil Above $100 Is Creating a New Opportunity Beyond the Major Producers
- Is Nike’s Index Demotion a Warning or a Buying Opportunity?
Receive News & Ratings for Olympus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olympus and related companies with MarketBeat.com's FREE daily email newsletter.
